COLL vs HCA · P/E 17, rev $181.9M vs P/E 17, rev $75.60B
Collegium Pharmaceutical Inc (COLL) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the COLL and HCA stock pages for the full models.
Not investment advice.